The SPUR Peripheral Retrievable Stent System (Reflow Medical) is the first retrievable
below-the-knee (BTK) scaffold technology approved in the United States, designed to
enhance luminal gain in complex tibial and infrapopliteal disease. Real-world outcome…

The Zenith Iliac Branch Device (ZBIS; Cook Medical) was approved for commercial use
in aortoiliac or isolated iliac artery aneurysms in May 2025. Although ZBIS trial
results showed excellent survival and freedom from secondary interventions, trial
results…

The profunda femoris artery (PFA), usually exposed lateral to the sartorius, is an
alternative inflow source for infrainguinal bypasses, usually utilized to avoid a
reoperative common femoral artery (CFA) exposure. However, there is a paucity of studies
comparing…

Operative case conversions are an important component of building an elective clinical
practice and influence compensation within productivity-based models. Large health
systems often prioritize access over previsit screening within centralized scheduling…

As the population ages, more octogenarians require hemodialysis access, yet the optimal
modality remains unclear. Brachiobasilic arteriovenous fistulas (BBFs) offer superior
long-term patency and lower infection risk but require longer maturation. Arteriovenous…

The GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis (TAMBE) received recent commercial
approval in the United States. We sought to characterize the visceral branch curvature
of the device in real-world use.

Type B aortic dissection (TBAD) is managed with medical therapy or thoracic endovascular
aortic repair (TEVAR). Aortic insufficiency (AI) may be influenced by changes in afterload
and aortic geometry following dissection and its management, though its impact…

Confirmation of aortic vascular graft and endograft infection (VGEI) is highly consequential
in terms of intervention and prognosis. Using the Management of Aortic Graft Infection
Collaboration (MAGIC) definition, this study aimed to investigate the progression…

The Centers for Medicare and Medicaid Services revised lower-extremity peripheral
intervention current procedural terminology (CPT) codes for 2026, introducing complexity-based
coding for occlusive disease along with expanded add-on codes for additional vessels…

Worse women’s outcomes after elective standard endovascular aneurysm repair have been
widely reported. Similar data have surfaced from cohorts undergoing fenestrated and
branched repair; however, studies reporting from a sex perspective are rare and mostly…

Autologous fistula creation in octogenarians is challenging, as differences in vessel
caliber and hemodynamics between fistula types may affect time to functional use in
patients with limited life expectancy. Our study evaluated time-to-index cannulation…

Paclitaxel coated balloons have been used to prevent recurrent stenosis in haemodialysis
vascular access. Despite the availability of many randomised controlled trials (RCTs),
its effectiveness compared with plain balloon angioplasty remains inconclusive.…

Incomplete thrombus resolution after deep vein thrombosis (DVT) traps venous valves
and restricts venous return, leading to post-thrombotic syndrome (PTS). Despite anticoagulation,
>40% of patients progress to PTS. Anticoagulation prevents thrombus progression…

Endovascular aortic aneurysm repair (EVAR) is associated with substantial health care
expenditure. Identifying factors associated with high-cost outliers may inform strategies
to optimize resource utilization and cost containment.

News items of interest to the vascular surgeon must be received at least eight (8)
weeks before the desired month of publication. Announcements published at no charge
include those received from a sponsoring society of this Journal, those courses and
conferences…

Arteriovenous fistula (AVF) creation is the preferred modality for permanent hemodialysis
access due to superior durability and lower infection risk. Procedure cancellations
represent a major and underrecognized barrier to timely access, particularly in …

Laser in situ fenestrated endovascular (LIFE) repair allows fenestrated endovascular
aortic repair in complex and challenging cases, including urgent and emergency presentations
and patients with prior aortic repairs. We present the results of this unique…

Periprocedural clopidogrel, with or without aspirin, is standard-of-care after several
endovascular interventions. CYP2C19 is the primary enzyme that metabolizes clopidogrel
to its bioactive form. The wildtype CYP2C19*1 allele imparts normal metabolism and…

Medical management is the first-line therapy for uncomplicated type B aortic dissection
(uTBAD). Identification of admission computed tomographic (CT) features associated
with aortic enlargement may enhance patient-specific surveillance protocols. We describe…

The 2015 Medicare Access and CHIP Reauthorization Act shifted physician reimbursement
toward a value-based model through the Quality Payment Program (QPP). One component
of the QPP is the merit-based incentive payment system (MIPS), which ties payments
to…